EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year gross profit growth rate
| Period | Value |
|---|---|
| Q3 2025 | -95.26% |
| Q2 2025 | -78.15% |
| Q1 2025 | 119.53% |
| Q4 2024 | 10.05% |
| Q3 2024 | 21.20% |
| Q2 2024 | -26.08% |
| Q1 2024 | -16.16% |
| Q4 2023 | -6.93% |
| Q3 2023 | 91.44% |
| Q2 2023 | 3.83% |
| Q1 2023 | -1.12% |
| Q4 2022 | -17.24% |
| Q3 2022 | -12.45% |
| Q2 2022 | 30.78% |
| Q1 2022 | -11.68% |
| Q4 2021 | 17.65% |
| Q3 2021 | 2.12% |
| Q2 2021 | 19.40% |
| Q1 2021 | 27.04% |
| Q4 2020 | -66.19% |
| Q3 2020 | 281.57% |
| Q2 2020 | -44.38% |
| Q1 2020 | -10.95% |
| Q4 2019 | 234.97% |
| Q3 2019 | -66.45% |
| Q2 2019 | 286.68% |
| Q1 2019 | 196.83% |
| Q4 2018 | 69.78% |
| Q3 2018 | -41.90% |
| Q2 2018 | -68.96% |
| Q1 2018 | 28.15% |
| Q4 2017 | -966.49% |
| Q3 2017 | -45.08% |
| Q2 2017 | 125.64% |
| Q1 2017 | -197.43% |
| Q4 2016 | 180.98% |
| Q3 2016 | 8.82% |
| Q2 2016 | -38.18% |
| Q1 2016 | 13.93% |
| Q4 2015 | -5.94% |